Baird Maintains Neutral on Definitive Healthcare, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Vikram Kesavabhotla maintains a Neutral rating on Definitive Healthcare (NASDAQ:DH) and lowers the price target from $6 to $5.
August 07, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Baird analyst Vikram Kesavabhotla maintains a Neutral rating on Definitive Healthcare and lowers the price target from $6 to $5.
The lowered price target from $6 to $5 suggests a less optimistic outlook for Definitive Healthcare, which could negatively impact investor sentiment and short-term stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100